Combines Panthenol's tissue-repair properties with Biotin's keratin-supporting carboxylase pathway.
Source5
Living ingredient passport
비오틴 · 전성분
An essential B-complex vitamin (Vitamin B7 / Vitamin H) that serves as a carboxylase coenzyme supporting keratin and fatty-acid metabolism; a topical encapsulated form has been linked to reduced hair-pull-test shedding in a small clinical cohort 1, and oral biotin may support nail firmness in people with brittle nail syndrome or a documented deficiency 2.
Also called Vitamin B7 · Vitamin H · D-Biotin · Coenzyme R
This ingredient page is still early. We're actively researching before it's ready to stand fully on its own — check back as more sections are verified.
Four lines, each compressed from the section it links to. Every line carries the sources of the claim it compresses.
Reduction of Hair Shedding and Shaft Thickness Increase, Topical Encapsulated Biotin
See the evidencescalp serum step · day and night
See how to use it30 days: In the reviewed study, a significant reduction in pull-test hair shedding was observed at this point.
Source1
See the timelineWhere it sits in the seven-step ladder, and the record's own fields for the habit.
day and night
Filled steps are where Biotin commonly appears. No product is recommended.
Everything here comes from the sources below. None of it is a product recommendation.
One card per pair. Where the partner has its own passport, the name links to it.
Combines Panthenol's tissue-repair properties with Biotin's keratin-supporting carboxylase pathway.
Source5
The record's own timeline. Each step keeps the source of the study it came from.
Initial scalp hydration and conditioning.
In the reviewed study, a significant reduction in pull-test hair shedding was observed at this point.
Source1
In the reviewed study, a further significant reduction in pull-test hair shedding and increase in hair-shaft thickness median was observed.
Source1
Everything the record says about suitability, consolidated. Pause-first comes first.
Before you start
Topically exceptionally gentle and non-irritating. High-dose oral biotin supplementation is documented to interfere with clinical blood immunoassay tests, including cardiac troponin and thyroid panels, producing falsely normal or falsely abnormal results -- tell your doctor about any biotin supplement before bloodwork 6.
Reported with a near-zero irritation and sensitization rate across skin and scalp types in the reviewed study.
hair shedding
thinning hair · weak hair shaft · brittle nails
scalp serum step
Not medical advice · ask your own clinician
Pregnancy. A 2011 dermatology review of skin-care product safety in pregnancy names hydroquinone (high systemic absorption) and tretinoin (evidence controversial) as the actives of concern, and states that most other topical skin-care products act locally and produce minimal systemic absorption; biotin is not named among the flagged concerns 7. This is general topical-product reasoning rather than an ingredient-specific safety trial, and does not address oral biotin supplementation. If you are pregnant, ask your doctor before use.
Breastfeeding. Topical application is applied locally with minimal expected systemic absorption; no ingredient-specific breastfeeding safety trial was located. As a general precaution common to topical actives, avoid applying directly to the breast or nipple area, since incidental transfer to a nursing infant has not been studied for this ingredient. If you are breastfeeding, ask your doctor before use.
| Common, and it usually settles | Stop using it |
|---|---|
| A comfortable feeling on application with no stinging or flaking reported in the reviewed study. | persistent scalp redness |
| localized itching | |
| rash or swelling |
A dedicated search of the peer-reviewed literature (PubMed) for biotin topical allergic contact dermatitis, contact allergy, and sensitization case reports found one historical case study noted within the 2001 CIR safety assessment, alongside a very large population exposed to biotin daily with no parallel pattern of adverse reactions 4. This is a genuine, if sparse, literature record rather than a confirmed absence.
Research in progress — check back soon. How we verify
One card per claim. Concentration, form, population and limitation sit with it, always visible.
In a small single-arm cohort study, daily topical application of an encapsulated water-soluble D-Biotin serum was linked to a significant reduction in pull-test hair shedding and a significant increase in hair-shaft thickness.1
In individuals with brittle nail syndrome or a documented biotin deficiency, case-report-level evidence suggests oral biotin supplementation (2.5 mg daily) may improve nail plate firmness and reduce splitting; evidence in people without an underlying deficiency is not established.2
A quantified randomized controlled trial of oral biotin specifically measuring nail plate thickness or firmness as a percentage change in individuals with brittle nail syndrome or documented biotin deficiency.
Large-scale, multi-center, double-blind, randomized controlled clinical trials comparing topical encapsulated biotin monotherapy vs vehicle control in healthy individuals without diagnosed hair shedding, and an independent (non-sponsor-funded) replication of the topical hair-shedding trial this record relies on.
Biotin (Vitamin B7) is an essential coenzyme for carboxylase enzymes involved in fatty-acid synthesis and amino-acid catabolism within epidermal and follicular cells. The topical trial's own introduction reports that biotin deficiency is linked to hair loss and brittle nails, and that the authors' earlier in-vitro work found encapsulated biotin upregulated hair-related keratins (KRT40, KRT85) and dermal-papilla growth factors (VEGF, FGF7, IGF1) in cultured human cells 1.
Serves as a coenzyme for carboxylase enzymes involved in fatty-acid synthesis and amino-acid catabolism; biotin deficiency is linked to hair loss and brittle nails.
What that rests on: reported background, prospective clinical cohort study
Source1
Encapsulated water-soluble biotin is reported to penetrate the follicular infundibulum toward the dermal papilla; the study's authors report their own earlier in-vitro work found this form upregulated hair-related keratins (KRT40, KRT85) and dermal-papilla growth factors (VEGF, FGF7, IGF1).
What that rests on: reported background (prior in-vitro work) plus clinical pull-test and phototrichogrammetry
Source1
| Attribute | D-Biotin (Pure Biotin) | Encapsulated Water-Soluble Biotin (Serum WS Biotin) |
|---|---|---|
| What it is | The pure, biologically active dextrorotatory enantiomer (D-Biotin) recognized and utilized by mammalian carboxylase enzymes; the form used orally. | Provides enhanced trans-follicular absorption compared to unencapsulated crystalline biotin; the form tested topically. |
| Official INCI | BIOTIN | BIOTIN |
| Where it comes from | Synthetic chemical synthesis or microbial fermentation | Synthetic synthesis and liposomal vesicle encapsulation |
| How it is made | Synthesized chemically or via microbial fermentation to yield the biologically active D-stereoisomer, followed by multi-stage crystallization and high-purity filtration. | Pure D-Biotin is encapsulated into amphiphilic lipid micro-vesicles to overcome crystalline water insolubility and enhance trans-follicular penetration toward the dermal papilla. |
| Gentleness | No topical exposure; oral use carries a diagnostic-test-interference caution, not a skin-tolerance one. | Hypoallergenic and non-irritating on skin and scalp in the reviewed study. |
Source4
Source5
Daily application for 90 days in 22 volunteers significantly reduced pulled hairs (Modified Pull Test) by 43.0% at Day 30, 56.0% at Day 60, and 76.1% at Day 90, and significantly increased hair-thickness median by 7.5% at Day 30, 10.6% at Day 60, and 7.6% at Day 90. Hair-thickness mean and hair mass also increased but did not reach statistical significance.
Where it falls shortSingle-arm study design without a concurrent vehicle-controlled placebo group. The study was partially funded by, and several authors are affiliated with, Tagra Biotechnologies, the manufacturer of the tested Serum WS Biotin product.
Source1
Found 18 reported cases of biotin use for hair and nail changes; in all cases patients had an underlying pathology (acquired or inherited biotin deficiency, brittle nail syndrome, or uncombable hair syndrome) and showed clinical improvement after biotin supplementation. Evidence for supplementation in healthy, non-deficient individuals remains limited.
Where it falls shortCase-report-level review, not a quantified randomized controlled trial; does not report a specific percentage change in nail thickness.
Source2
Three studies met inclusion criteria. The highest-quality study (double-blind, placebo-controlled) found no difference between biotin and placebo groups for hair growth. The other two studies, in specific patient populations (isotretinoin users and post-sleeve-gastrectomy patients), were susceptible to multiple biases with no striking results favoring biotin. The review does not address nail outcomes.
Where it falls shortLimited to oral administration studies of hair outcomes; does not evaluate nails, and is limited by a small number of available studies.
Source3
The CIR Expert Panel reviewed updated information available since the original 2001 assessment and reaffirmed that Biotin is safe as a cosmetic ingredient in the practices of use and concentration described in the report.
Where it falls shortA panel safety reaffirmation rather than a new primary clinical trial; covers cosmetic-use safety, not topical or oral efficacy.
Source4
South Korea MFDS official regulation establishing that the specific combination of Biotin 0.06% with Niacinamide, Dexpanthenol, and Zinc Pyrithione qualifies for document-exempt functional cosmetic status for hair loss alleviation.
Where it falls shortApplies strictly to the specified functional combination in hair-care products, not to biotin alone.
Source5
Confirmed that biotin supplementation can cause falsely lowered high-sensitivity cardiac troponin T results in real-world acute cardiac care, a risk relevant to any oral biotin use, including doses used for hair or nail support.
Where it falls shortFocused on troponin T specifically; other biotin-streptavidin-based immunoassays (e.g., thyroid panels) are affected by the same mechanism per separate literature, not re-verified here.
Source6
Source7
A quantified randomized controlled trial of oral biotin specifically measuring nail plate thickness or firmness as a percentage change in individuals with brittle nail syndrome or documented biotin deficiency.
This record cannot state a specific percentage improvement in nail thickness from oral biotin -- the reviewed case-report literature describes qualitative clinical improvement across 18 cases without a quantified effect size.
NeedsA double-blind, randomized, placebo-controlled trial of oral biotin (2.5 mg daily or higher) measuring nail plate thickness by a validated instrumental method in a cohort with brittle nail syndrome or documented biotin deficiency.
Large-scale, multi-center, double-blind, randomized controlled clinical trials comparing topical encapsulated biotin monotherapy vs vehicle control in healthy individuals without diagnosed hair shedding, and an independent (non-sponsor-funded) replication of the topical hair-shedding trial this record relies on.
The isolated topical hair-shedding effect in a general healthy population, and independent of the manufacturer's own funding, remains a clinical estimation from a single sponsor-funded, single-arm study.
NeedsAn independently funded, double-blind, vehicle-controlled trial of topical encapsulated biotin on pull-test hair shedding in at least 100 subjects over 90 days.